The Colorado Department of Public Health and Environment projected that new HIV diagnoses will total 482 in 2024 — virtually ...
Gilead (NASDAQ:GILD) on Tuesday announced encouraging initial data from an ongoing Phase 1 trial for lenacapavir, an ...
LGBT+ groups and public health advocates warn against potential threats that could jeopardize progress and ‘set us back ...
The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic HIV prevention, The Wall Street Journal reports. The discussions come as ...
GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its plans to create a six-month regimen are shaping up. ViiV, which is ...
The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...